Ajinomoto logo

Ajinomoto

Last updated January 31, 2026
72
Innovation Areas
1,635
Inventors
14
Collaborations

High-density perfusion bioreactor parameters: AjinomotoRecent Research Landscape

Inconsistent cell phenotype and batch-to-batch variability during expansion increase clinical manufacturing risks. These innovations stabilize the cellular microenvironment through precise nutrient and growth factor titration.

What technical problems is Ajinomoto addressing in High-density perfusion bioreactor parameters?

Insufficient volumetric protein productivity

(9)evidences

Standard culture media fail to maintain cell viability and pluripotency during high-density expansion. Stabilizing the chemical environment prevents premature cell differentiation and metabolic exhaustion.

Hyperosmotic cell growth inhibition

(2)evidences

Spontaneous clustering of cells in high-density cultures restricts nutrient access and hinders downstream processing. Preventing these physical obstructions ensures uniform nutrient distribution and consistent harvest yields.

Insufficient progenitor cell yields

(2)evidences

Initial extraction from living tissue often results in insufficient quantities of viable progenitor cells. Increasing the starting population density is critical for therapeutic scalability.